Abstract : Chronic hepatitis B and D infections are major causes of liver disease and hepatocellular carcinoma worldwide. Efficient therapeutic approaches for cure are absent. Sharing the same envelope proteins, hepatitis B virus and hepatitis delta virus use the sodium/taurocholate cotransporting polypeptide (a bile acid transporter) as a receptor to enter hepatocytes. However, the detailed mechanisms of the viral entry process are still poorly understood. Here, we established a high-throughput infectious cell culture model enabling functional genomics of hepatitis delta virus entry and infection. Using a targeted RNA interference entry screen, we identified glypican 5 as a common host cell entry factor for hepatitis B and delta viruses. CONCLUSION: These findings advance our understanding of virus cell entry and open new avenues for curative therapies. As glypicans have been shown to play a role in the control of cell division and growth regulation, virus-glypican 5 interactions may also play a role in the pathogenesis of virus-induced liver disease and cancer
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01796197
Contributor : Lauriane Pillet
<>
Submitted on : Saturday, May 19, 2018 - 11:34:31 AM
Last modification on : Friday, June 28, 2019 - 9:38:04 AM
Eloi R. Verrier, Che C. Colpitts, Charlotte Bach, Laura Heydmann, Amélie Weiss, et al.. A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses. Hepatology, Wiley-Blackwell, 2016, 63 (1), pp.35-48. ⟨http://doi.wiley.com/10.1002/hep.28013⟩. ⟨10.1002/hep.28013⟩. ⟨hal-01796197⟩
